As the medical device industry transitions to a highly consumer-driven marketplace, incorporating user feedback into new ...

Samsung's venture arm is looking to invest in California-based medical device startup Exo, Bloomberg reported.

On Tuesday, May 27, an analyst from BTIG downgraded Globus Medical Inc. (NYSE:GMED) from Buy to Neutral, citing concerns about its Spine business. The analyst did not assign a price target following ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $77.5, a high ...

BTIG analysts have downgraded (NYSE:GMED) from "Buy" to "Neutral" amid fears surrounding the company's Spine business.

Chester County Futures (CCF), in collaboration with Globus Medical, recently provided a transformative learning experience ...

Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. The firm engages in developing products that promote healing in patients with ...

From new partnerships and launches, here are six developments from Globus Medical so far in 2025. 1. OsteoCentric Technologies entered into a non-exclusive licensing agreement with Globus Medical.

The United States market has experienced a positive trend, rising 2.9% over the last week and 12% over the past year, with earnings projected to grow by 14% annually in the coming years. In this ...

Globus Medical (NYSE:GMED) announced that its board of directors authorized a share repurchase program totaling up to $500 ...

Looking back on medical devices & supplies - specialty stocks’ Q1 earnings, we examine this quarter’s best and worst ...

About Globus Medical, Inc. Globus Medical ... our success in defending legal proceedings brought against us, trends in the medical device industry, general economic conditions, and other risks.